XML 50 R37.htm IDEA: XBRL DOCUMENT v3.25.3
MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Eli Lilly and Company (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2025
USD ($)
target
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Revenues   $ 581,000 $ 49,412,000 $ 25,324,000 $ 50,249,000  
Deferred revenues   7,556,000   7,556,000   $ 7,556,000
Eli Lilly and Company | Recognition of license revenue            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Number of targets | target 1          
Number of additional targets | target 4          
Contract with customer liability $ 18,000,000          
Variable consideration amount $ 1,400,000,000          
Royalty obligation, term 10 years          
Revenue from contract with customer, number of potential targets | target 5          
Revenues   0   18,000,000    
Deferred revenues   $ 0   $ 0